Last reviewed: June 17, 2026
Last updated: June 17, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide works by activating GLP-1 receptors in your brain to reduce hunger and improve metabolic control, with clinical trials showing average weight loss of 10-15% over six months at standard doses. Understanding how dosing progresses helps you anticipate your treatment timeline and set realistic expectations. PlexusDx delivers personalized semaglutide therapy starting at $149 per month, with doses adjusted based on your individual response rather than a fixed protocol.
How Semaglutide Dosing Schedules Work for Weight Management
Semaglutide treatment follows a gradual titration schedule designed to minimize side effects while building therapeutic benefit. Most protocols start at 0.25 mg injected once weekly, then increase by 0.25 mg increments every four weeks until reaching a maintenance dose between 1.0 and 2.4 mg weekly. This slow escalation allows your digestive system and appetite centers to adapt progressively, reducing nausea and tolerability issues that can occur with faster dose increases.
The timing of your dose escalation depends entirely on how your body responds and how well you tolerate each level. Some patients reach their optimal weight-loss dose at 1.0 mg weekly, while others benefit from continuing to 1.7 mg or 2.4 mg based on hunger signals and metabolic feedback. PlexusDx supports flexible titration schedules that match your individual tolerance, meaning your dose may need to go up—but your price won't stay flat at $149 per month across all dose levels.
Standard Semaglutide Dose Ranges and Weight Loss Outcomes
Clinical evidence shows that semaglutide's weight-loss benefit increases with dose, with the greatest effects occurring between 1.0 and 2.4 mg weekly. In the STEP trials (Semaglutide Treatment Effect in People with Obesity), participants taking 2.4 mg weekly lost an average of 14-15% of their baseline body weight over 68 weeks, compared to 2-3% in the placebo group. Maintenance doses below 1.0 mg typically produce modest weight loss, while doses in the 1.0-1.7 mg range offer a balance between efficacy and side-effect tolerability for most patients.
Your optimal semaglutide dose is not one-size-fits-all; it depends on your starting weight, metabolic rate, GLP-1 receptor sensitivity, and personal tolerability. Some patients experience significant appetite suppression and weight loss at 0.5 mg weekly, while others require 1.7-2.4 mg to achieve the same hunger reduction. PlexusDx can help identify your likely response profile using the Precision Peptide Genetic Test, which analyzes your GLP1R rs6923761 variant and 48 other peptide-pathway markers to predict your medication sensitivity.
Why Personalization Matters More Than Average Dosing
The concept of an 'average dose' can be misleading because semaglutide response varies dramatically between individuals based on genetics, gut bacteria, liver function, and prior weight-loss attempts. A patient with a GLP1R variant that enhances receptor sensitivity may reach their weight-loss plateau at 0.75 mg, while someone with lower GLP1R expression might need 2.0 mg to achieve comparable results. Relying on population averages rather than personalized dosing often leads to either overmedication (unnecessary side effects) or undermedication (inadequate appetite control and slower weight loss).
PlexusDx tailors your starting dose and titration schedule based on your medical history, current medications, and genetic predispositions mapped through 14 metabolic pathways. This precision approach reduces trial-and-error adjustments, accelerates your path to an effective dose, and minimizes the likelihood of premature discontinuation due to side effects. Your PlexusDx provider reviews your response at each dose level and adjusts timing based on your hunger signals, energy levels, and weight-loss progress rather than following a rigid calendar.
Comparing Compounded Semaglutide Flexibility and Access
Compounded semaglutide from licensed 503A pharmacies offers dosing flexibility that brand-name Wegovy sometimes cannot match, allowing for micro-adjustments between standard dose increments when your response warrants fine-tuning. Because PlexusDx compounds semaglutide in-house through licensed 503A providers, your dose can be customized to any amount—not just the predefined pen doses of commercial products. This means if you need 0.6 mg or 1.4 mg instead of the standard 0.5 mg or 1.0 mg steps, your prescription can be adjusted without delay.
PlexusDx compounded semaglutide injection is available to all 50 states without insurance requirements or membership fees, and it qualifies for HSA and FSA reimbursement. Starting at $149 per month flat, your cost remains predictable regardless of dose adjustments, allowing you to focus on finding your optimal therapeutic level without financial uncertainty. Unlike brand-name GLP-1 products that require prior authorization or step-therapy protocols, PlexusDx semaglutide can begin immediately upon consultation, with dose titration managed directly by your assigned provider.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the typical starting dose of semaglutide for weight loss?
Most semaglutide protocols begin at 0.25 mg injected once weekly, then increase by 0.25 mg every four weeks based on tolerance and response. PlexusDx providers may adjust your starting point if you have specific medical conditions or prior medication sensitivities, ensuring your titration schedule matches your individual needs rather than a standard template.
How long does it take to reach an effective semaglutide dose?
The standard 16-week titration schedule brings most patients to a maintenance dose of 1.0-1.7 mg by week 16, though some reach benefit sooner and others require extension to 2.4 mg. PlexusDx supports flexible timelines—if you're tolerating your dose well and seeing good appetite suppression, your provider can recommend staying at that level rather than escalating on a fixed calendar.
Why is PlexusDx semaglutide the same price at all dose levels?
PlexusDx prices compounded semaglutide at a flat $149 per month regardless of your dose because your cost should not be a barrier to finding your optimal therapeutic level. This pricing model ensures that dose adjustments—whether up or down—never trigger unexpected bill increases, allowing you to pursue the dose that works best for your body without financial stress.
Can I stop escalating my semaglutide dose if I'm happy with my weight loss?
Yes—your dose escalation should be guided by your results and tolerance, not a preset schedule. If you're experiencing good appetite control, steady weight loss, and manageable side effects at 1.0 mg weekly, remaining at that dose is a perfectly valid treatment strategy. Your PlexusDx provider reviews your progress monthly and adjusts only when clinical benefit justifies further changes.
How does the Precision Peptide Genetic Test help predict my ideal semaglutide dose?
PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R rs6923761 variant, FTO rs9939609, and 47 other peptide-pathway markers to predict your medication sensitivity and weight-loss responsiveness. Patients with enhanced GLP1R expression often achieve results at lower doses, while those with reduced expression may need higher maintenance levels—the test helps your provider anticipate this from day one rather than discovering it through trial-and-error dosing.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Navigating Health: Can You Take Ozempic with COVID-19?
Navigating Your Medications: What Not to Take with Ozempic and How to Stay Safe